Understanding thyroid hormone action defects
Official title: Advancing Understanding, Diagnosis and Monitoring of Thyroid Hormone Action Defects (ADAM-THAD)
Run by Istituto Auxologico Italiano · NCT06307990 · Data updated 2026-11-12
This study is trying to learn more about how thyroid hormone problems affect the brain and heart in newborns and patients with unexplained symptoms, to help with early diagnosis and better monitoring.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Istituto Auxologico Italiano Academic / other |
| Locations | 2 sites (Milan and 1 other locations) |
| Status | Recruiting |
| Started | January 1, 2023 |
| Main results expected | October 31, 2025 |
| Study ends | January 31, 2026 |
| Registry record updated | September 2, 2025 |
| Trial ID | NCT06307990 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include newborns with biochemical signatures suggestive of thyroid hormone resistance or individuals with known diagnoses of these syndromes.
✕Probably not a fit
Patients without biochemical or symptomatic evidence of thyroid hormone resistance will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the neurological and cardiological features of patients with resistance to thyroid hormone syndromes, specifically focusing on the genetic variants affecting thyroid hormone receptors. It seeks to define the frequency of these syndromes, improve early diagnosis, and develop monitoring tools through biochemical and genetic investigations. Participants will include newborns and patients with unexplained neuro-cognitive or cardiovascular symptoms, and pluripotent stem cells will be generated for in vitro studies to explore the underlying molecular mechanisms. The study will correlate clinical data with laboratory findings to enhance understanding of these rare conditions.
Why it matters
Potential benefit: If successful, this study could lead to earlier diagnosis and better management of thyroid hormone resistance syndromes, potentially reducing adverse health outcomes.
How similar studies have gone: While there have been studies on thyroid hormone action defects, this approach focusing on early diagnosis and monitoring tools is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \- biochemical signature suggestive of RTHs syndromes at birth (a) or symptoms suggestive of RTHs syndromes (b) or known diagnosis of RTHs syndromes (c) Exclusion Criteria: * none
Where it's running
-
Istituto Auxologico Italiano IRCCS
Milan, Italy Recruiting -
Department of Endocrine & Metabolic Diseases, San Luca Hospital
Milan, Italy Recruiting
Study contacts
- Study coordinator: Luca Persani, Prof
- Email: luca.persani@unimi.it
- Phone: 02619112738
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if the Doraldo-Castelletti scale helps decide if migraine patients should see a physiotherapist
This study tests whether a brief cervical screening scale can help neurologists decide which migraine patients might benefit from physiotherapy.
-
MicroRNA and bone markers linked to response to romosozumab and abaloparatide in postmenopausal osteoporosis
Researchers will test whether microRNA and other bone markers can predict how well postmenopausal women with osteoporosis respond to romosozumab and abaloparatide.
-
How obesity affects daily activities and physical abilities in older adults
This study tests how excess weight in people over 65 impacts daily tasks and physical performance, comparing obese seniors to normal-weight peers.
-
Multisensory neuromodulation to improve visual field loss after stroke
This will try combining audio-visual training with noninvasive brain stimulation (tDCS) to help people within three months of stroke who have homonymous hemianopsia improve their visual field and visual scanning.
-
Longitudinal integrated biomarker profiling linked to ALS clinical features
This project will test whether repeated blood and spinal-fluid biomarker measurements combined with deep clinical profiling can help predict disease course in adults with ALS.
-
Needs of adults with the C9orf72 form of ALS and their caregivers
This online survey will try to describe care and quality-of-life needs for adults with ALS who have the C9orf72 mutation and for their caregivers in Italy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.